Balance Sheet for Zealand Pharma A/S (ZEAL)

$ 35.855   1.095 (+3.15%) Volume: 2.55k 10:55 AM EDT 2-Jul-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 162,243 132,176 94,878 45,767 60,935
Restrictable Cash - - - 1,927 3,114
Marketable Securities 44,941 45,861 12,105 - -
Accounts Receivable 113 503 3,486 1,629 23,012
Loans Receivable - - - - -
Other Receivables 375 60 258 130 984
Receivables 2,369 1,204 5,175 3,169 25,384
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 4,616 1,803 1,169 1,959 354
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 214,169 181,044 113,327 52,823 89,786
Land and Improvements - - - - -
Buildings and Improvement 15,855 1,659 1,741 1,517 1,567
Machinery, Furniture and Equipment 10,840 9,318 9,349 7,188 10,956
Construction in Progress 2,101 - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 28,797 10,977 11,090 8,705 12,523
Gross Fixed Assets 28,797 10,977 11,090 8,705 12,523
Accumulated Depreciation (9,986) (8,577) (8,493) (6,774) (10,130)
Net Fixed Assets 18,811 2,400 2,597 1,931 2,394
Intangibles 372 - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets - - 950 43,190 -
Total Non-Current Assets 25,883 7,829 5,487 45,502 2,782
Total Assets 240,052 188,872 118,813 98,324 92,568
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 14,156 8,419 6,395 7,099 6,666
Short Term Debt 1,154 - 443 476 -
Notes Payable - - - - -
Accrued Expenses - - 692 1,381 1,385
Accrued Liabilities - - 692 1,381 1,385
Deferred Revenues 8,442 - - - 304
Current Deferred Income Taxes (808) 6,723 (886) (779) (855)
Other Current Liabilities 5,533 9,015 4,683 3,438 1,980
Total Current Liabilities 29,285 17,434 12,213 12,393 10,334
Long Term Debt N/A N/A 21,432 46,553 45,534
Deferred Income Tax 12,552 - - - -
Other Non-Current Liabilities 12,552 - - - -
Minority Interest - - - - -
Capital Lease Obligations 11,716 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 24,269 - 21,432 46,553 45,534
Total Liabilities 53,554 17,434 33,645 58,946 55,869
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 186,498 171,438 85,168 39,378 36,700
Common Par 5,411 4,728 4,956 3,700 3,543
Additional Paid in Capital 397,728 304,011 315,744 204,011 183,793
Cumulative Translation Adjustments - - - - -
Retained Earnings (216,641) (137,300) (235,532) (168,333) (150,636)
Treasury Stock - - - - -
Other Equity Adjustments - - - - -
Total Capitalization 186,498 171,438 106,600 85,931 82,234
Total Equity 186,498 171,438 85,168 39,378 36,700
Total Liabilities & Shareholder's Equity 240,052 188,872 118,813 98,324 92,568
Cash Flow (85,776) 89,273 (44,361) (21,786) (16,581)
Working Capital 184,883 163,610 101,113 40,429 79,452
Free Cash Flow (64,979) (71,328) (46,087) 5,422 (33,291)
Invested Capital 186,498 171,438 106,600 85,931 82,234
Shares Outstanding - Common Class Only 35,990 30,723 30,687 25,578 23,789
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 5,401 4,718 4,946 3,621 3,461
Total Common Shares Outstanding 35,990 30,723 30,687 25,578 23,789
Treasury Shares 10 10 10 - -
Basic Weighted Shares Outstanding 5,073 4,713 4,489 3,441 3,354
Diluted Weighted Shares Outstanding 5,073 4,713 4,489 3,441 3,354